PT  - JOURNAL ARTICLE
AU  - Glebov, Oleg O.
AU  - Mueller, Christoph
AU  - Stewart, Robert
AU  - Aarsland, Dag
AU  - Perera, Gayan
TI  - Antidepressant drug prescription and incidence of COVID-19: a retrospective cohort study
AID  - 10.1101/2022.12.15.22283507
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.12.15.22283507
4099  - http://medrxiv.org/content/early/2022/12/20/2022.12.15.22283507.short
4100  - http://medrxiv.org/content/early/2022/12/20/2022.12.15.22283507.full
AB  - While antidepressant drugs (ADs) have shown some efficacy in treatment of COVID-19, their preventative potential remains unexplored. To investigate association between AD and COVID-19 incidence in the community, we analysed data from community-living, non-hospitalized adults admitted to inpatient care of the South London&’Maudsley (SLaM) NHS Foundation Trust during the 1st wave of COVID-19 pandemic in the UK. Prescription of ADs within the period of 1 to 3 months before admission was associated with an approximately 40% decrease in positive COVID-19 test results when adjusted for socioeconomic parameters and physical health. This association was specifically observed for ADs of the Selective Serotonin Reuptake Inhibitor (SSRI) class. These results suggest that ADs, specifically SSRIs, may help prevent COVID-19 infection in the community. Definitive determination of AD preventative potential warrants prospective studies in the wider general population.Question Is there an association between prescription of antidepressants and incidence of COVID-19 in the general population?Findings In this retrospective cohort study of mental health outpatients with a recent (1-3 months) antidepressant prescription, there was a statistically significant 40% decrease in positive COVID-19 tests. This association was specifically observed for the most commonly prescribed antidepressant class, Selective Serotonin Reuptake Inhibitors, and remained when adjusted for socioeconomic parameters and physical health.Meaning Antidepressant prescription was associated with lower incidence of COVID-19 in the community, warranting further investigation as prophylactics in prospective clinical studies.Competing Interest StatementRS declares research support received within the last 36 months from Janssen, GSK and Takeda.Funding StatementThis study was funded by: The Lewy Body Society and the National Natural Science Fund of China (OG). National Institute for Health Research Biomedical Research Centre at the South London and Maudsley NHS Foundation Trust and Kings College London (RS CM DA GP). National Institute for Health Research Applied Research Collaboration South London at Kings College Hospital NHS Foundation Trust and the DATAMIND HDR UK Mental Health Data Hub (RS).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB of King's Health Partners approved this work (project 21-059 KHP)I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present work are contained in the manuscript